DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

TESARO (NASDAQ: TSRO)

28.25 -1.34 (-4.53%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TSRO $28.25 -4.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.87
Previous Close $29.59
Daily Range $28.01 - $29.87
52-Week Range $22.15 - $47.89
Market Cap $1.0B
P/E Ratio -16.44
Dividend (Yield) $0.00 (0.0%)
Volume 146,815
Average Daily Volume 173,402
Current FY EPS -$4.53

Sector

Healthcare

Industry

Drugs

TESARO (TSRO) Description

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. Website: http://www.tesarobio.com/

News & Commentary

What Was Behind Tesaro Inc.'s 21% Pop?

Tesaro and Opko's rolapitant successfully achieved primary and secondary endpoints in reducing chemotherapy-induced nausea and vomiting.

TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog

TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog

Sector Update: Health Care Stocks End Mixed; Opko Health, Tesaro Climb After Submitting New Drug Ap

Sector Update: Health Care Stocks End Mixed; Opko Health, Tesaro Climb After Submitting New Drug Application for Anti-Nausea Medication

Sector Update: Health Care

TESARO Announces Submission Of Rolapitant New Drug Application To FDA

TESARO Announces Submission Of Rolapitant New Drug Application To FDA

TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss - Analyst Blog

TESARO's' (TSRO) CEO Lonnie Moulder on Q2 2014 Results - Earnings Call Transcript

Myriad Genetics Poised on Strong Fundamentals - Analyst Blog

Commit To Purchase Tesaro At $25, Earn 14.2% Annualized Using Options

Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape

TSRO Makes Bullish Cross Above Critical Moving Average

See More TSRO News...